# OnCo record martyn-caplin (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/martyn-caplin/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "martyn-caplin" ;
  schema:name "Martyn E. Caplin"@en ;
  schema:description "Led CLARINET, which showed lanreotide slows tumour growth and made somatostatin analogues first-line antiproliferative therapy for NETs."@en ;
  schema:url <https://onco.cc/people/martyn-caplin/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Caplin%20ME%5BAuthor%5D%20neuroendocrine%20lanreotide> ;
  onco:tag "neuroendocrine", "somatostatin", "uk" ;
  schema:jobTitle "Professor of Gastroenterology and Neuroendocrine Tumours, Royal Free Hospital and UCL" ;
  schema:sameAs <https://orcid.org/0000-0003-0177-1352> ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:institutions <https://onco.cc/institutions/royal-free-hospital/> ;
  onco:trials <https://onco.cc/trials/clarinet/> ;
  onco:journals <https://onco.cc/journals/endocrine-related-cancer/> ;
  schema:affiliation <https://onco.cc/institutions/royal-free-hospital/> .